Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
11/2001
11/21/2001EP1154983A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
11/21/2001CN1323292A Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
11/21/2001CN1075105C Polymerizable chiral compound and use thereof
11/21/2001CN1075062C 乙酸衍生物 Acetic acid derivatives
11/15/2001WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001US20010041674 Reacting a acetophenyl derivative with an aromatic aldehyde or heterocylic containing aldehyde derivative by aldol condentation followed by reduction
11/15/2001DE10021900A1 New 2-aroyl-3-amino-alkenonitrile, amide and thioamide derivatives, useful as herbicides and pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or fungicides
11/15/2001CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP0706527B1 Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001CN1321632A (4S,5S)-and (4R,5R)-gamma-methyl-delta-hydroxyl-alkanoic acid and its alkyl ester, preparation method and application
11/13/2001US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001US6316459 O-benzyloxime ethers and crop protection agents containing these compounds
11/08/2001WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001WO2001036367A3 Organic compounds
11/08/2001US20010039021 Polyketides
11/08/2001US20010038879 Solid delivery systems for aroma ingredients
11/07/2001EP1150665A2 Use of statins for treating viral infections
11/07/2001EP0871609B1 Cyclohexenone oxime ether metal salts
11/07/2001CN1320599A Limited 9-cis-isotretinoins
11/06/2001CA2193178C Matrix metalloprotease inhibitors
11/01/2001WO2001081291A2 The oxidation of ketones to esters using a tin substituted zeolite beta
11/01/2001WO2001080892A1 Preventives for influenza
11/01/2001US20010037023 Alkyl pyrimidines substituted piperidine derivatives are used as tachykinin antagonsit, useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorder, inflammation, and neurological disorders
10/2001
10/31/2001EP1149086A1 Novel process for the removal of a silyloxy protecting group from 4-silyloxy-tetrahydro-pyran-2-ones
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP0717620B1 Substituted 2-aminotetralins
10/31/2001CN1319596A Synthesis of 3,6-dialkyl 5,6-dihydro-4-hydroxide-2H-pyran-2-ketone
10/30/2001US6310245 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
10/30/2001US6310042 Derivatives of carbohydrates and compositions containing them
10/25/2001WO2001079204A1 Phenyl substituted 4-hydroxy tetrahydropyridone
10/25/2001WO2001079199A1 Acetylene derivatives and herbicides containing the same
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001DE10019145A1 New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides
10/24/2001EP1147085A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors / tnf-alpha converting enzyme (tace) inhibitors
10/24/2001EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001CN1319086A Anthranilic acid derivatives
10/23/2001US6307067 Palladium and boron co-catalyzed addition of oxygen nucleophiles to vinyl epoxides
10/23/2001US6307066 Process for producing simvastatin
10/23/2001US6306895 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
10/18/2001WO2001077097A2 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
10/18/2001US20010031429 (Meth) acrylate, polymer, photoresist composition, and pattern forming process making use of the composition
10/18/2001CA2405561A1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
10/17/2001EP1146032A1 Process for the production of alkanediol derivatives
10/17/2001EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001EP1144360A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
10/17/2001EP0865438B1 Oxymethoxy-3-aryl-pyrone derivatives
10/17/2001CN1318063A Process for obtaiing HMG-CoA reductase inhibitors of high purity
10/17/2001CN1318046A New salts of HMG-CoA reductase inhibitors
10/16/2001US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001US6303583 Continuous injection of 5-fluorouracil (5fu) for 3 to 48 hours once a week and oral administration of a mixture of 1-(tetrahydrofuryl)-5-fluorouracil and uracil (uft) one to four times a day for 3 to 7 days per week for cancer therapy
10/11/2001WO2001074770A1 C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/11/2001WO2001074355A1 Method for treating cells resistant to antineoplastic agents
10/11/2001WO2001017983A3 Method for producing rose oxide using halohydrins or epoxides
10/11/2001DE10016544A1 New phenyl-substituted cyclic keto-enol compounds useful e.g. as insecticides, acaricides, nematocides, acaricides, herbicides, ectoparasiticides, antifouling agents or intermediates
10/11/2001CA2829534A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001CA2404868A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001CA2401104A1 Method for treating cells resistant to antineoplastic agents
10/10/2001EP1142887A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140811A1 Novel herbicides
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140058A1 N-formyl hydroxylamine derivatives as antibacterial agents
10/10/2001EP1139760A1 Cyclohexenone oxime ether / (glyphosates / gluphosinates) suspension concentrates
10/10/2001CN1072665C Preparation of unsaturated cyclic ethers
10/09/2001US6300368 Anilide derivatives and antiarrhythmic agents containing the same
10/09/2001US6300106 Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
10/09/2001CA2202057C 5-lipoxygenase inhibitors
10/04/2001WO2001072734A1 A process for producing simvastatin
10/04/2001WO2001072688A2 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof
10/04/2001US20010026934 Conversion of compactin to pravastatin by actinomadura
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP0892774A4 Pyronin antibacterials, process and novel intermediates thereto
10/04/2001EP0891326B1 Novel vitamin d analogues
10/03/2001CN1315946A Process for selective lactonization
10/02/2001US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups
10/02/2001US6297008 Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis
09/2001
09/27/2001WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001017972A3 Novel herbicides
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000061537A3 Pharmaceutical compounds
09/27/2001US20010025105 Anticancer agent; Alzheimer's therapy
09/27/2001US20010025029 Novel stromelysin inhibitors
09/27/2001US20010024810 Libraries of polyketides synthesized by a multiplicity of polyketide synthases that are derived from naturally occuring synthases that contain regions that encode enzymatic activities and scaffolding amino acid sequences
09/27/2001CA2404131A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors
09/26/2001EP1136479A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 129